BR0104761A - Abamectin plus ivermectin combination for use as endectocide in cattle - Google Patents
Abamectin plus ivermectin combination for use as endectocide in cattleInfo
- Publication number
- BR0104761A BR0104761A BR0104761A BR0104761A BR0104761A BR 0104761 A BR0104761 A BR 0104761A BR 0104761 A BR0104761 A BR 0104761A BR 0104761 A BR0104761 A BR 0104761A BR 0104761 A BR0104761 A BR 0104761A
- Authority
- BR
- Brazil
- Prior art keywords
- abamectin
- ivermectin
- endectocide
- bovine
- parasites
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"ASSOCIAçãO DE ABAMECTINA MAIS IVERMECTINA PARA USO COMO ENDECTOCIDA EM BOVINOS". A associação de duas lactonas macrocíclicas, a Abamectina e a Ivermectina, tendo como veículo álcool benzílico, Acetato de Tocoferol e óleo de oliva, atua como endectocida de grande espectro. Trata-se de uma formulação de longa ação, estável, que deve ser administrada via subcutânea, em dose única, no combate a parasitas de bovinos, tais como: nematódeos gastrintestinais e pulmonares, bernes, carrapatos, sarnas e miíases cutâneas. Esta associação resulta em melhor aproveitamento das características terapêuticas de cada uma das substâncias associadas, quando comparadas à utilização de cada uma delas isoladamente, resultando menor custo e conseq³entemente melhor relação custo/benefício, atendendo de forma adequada às necessidades do criador e à finalidade proposta, exterminando de forma adequada os parasitas que prejudicam os rebanhos bovinos, com menor toxicidade e, finalmente, aumentando a produtividade e lucratividade dos rebanhos."ABAMECTIN ASSOCIATION MORE IVERMECTIN FOR USE AS AN ENDECTOCID IN BOVINE". The combination of two macrocyclic lactones, Abamectin and Ivermectin, having benzyl alcohol, Tocopherol Acetate and olive oil as their vehicle, acts as a broad spectrum endectocide. It is a stable, long-acting formulation that should be administered subcutaneously, in a single dose, to combat bovine parasites such as gastrointestinal and pulmonary nematodes, berns, ticks, scabies and skin myiasis. This association results in a better use of the therapeutic characteristics of each of the associated substances, when compared to the use of each one of them, resulting in lower cost and consequently better cost / benefit ratio, adequately meeting the creator's needs and the proposed purpose, properly exterminating parasites that harm cattle herds with less toxicity and ultimately increasing the productivity and profitability of the herds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0104761A BR0104761A (en) | 2001-08-08 | 2001-08-08 | Abamectin plus ivermectin combination for use as endectocide in cattle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0104761A BR0104761A (en) | 2001-08-08 | 2001-08-08 | Abamectin plus ivermectin combination for use as endectocide in cattle |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0104761A true BR0104761A (en) | 2003-08-12 |
Family
ID=27625742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0104761A BR0104761A (en) | 2001-08-08 | 2001-08-08 | Abamectin plus ivermectin combination for use as endectocide in cattle |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR0104761A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037294A1 (en) * | 2003-10-17 | 2005-04-28 | Akzo Nobel N.V. | Compositions for controlling parasites comprising a combination of abamectin and ivermectin |
WO2007053760A3 (en) * | 2005-11-01 | 2008-01-10 | Dow Agrosciences Llc | Pesticidally active compositions having enhanced activity |
-
2001
- 2001-08-08 BR BR0104761A patent/BR0104761A/en not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037294A1 (en) * | 2003-10-17 | 2005-04-28 | Akzo Nobel N.V. | Compositions for controlling parasites comprising a combination of abamectin and ivermectin |
AU2004281551B2 (en) * | 2003-10-17 | 2009-10-29 | Intervet International B.V. | Compositions for controlling parasites comprising a combination of abamectin and ivermectin |
CN1867341B (en) * | 2003-10-17 | 2010-06-16 | 英特威国际有限公司 | Compositions for controlling parasites comprising a combination of abamectin and milbemycin |
WO2007053760A3 (en) * | 2005-11-01 | 2008-01-10 | Dow Agrosciences Llc | Pesticidally active compositions having enhanced activity |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alley et al. | Cutaneous toxicities of cancer therapy | |
Langtry et al. | Sildenafil: a review of its use in erectile dysfunction | |
AR024516A1 (en) | BI-AROMATIC COMPOUNDS ANALOGS OF VITAMIN D, ITS USE, PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION THAT INCLUDE AT LEAST ONE OF SUCH COMPOUNDS AND USE OF SUCH COSMETIC COMPOSITION. | |
DE60120659D1 (en) | COMPOSITIONS CONTAIN CAROTENOIDS AND THEIR USE TO PREVENT HORMON-INDUCED SIDE EFFECTS | |
BR0209658A (en) | 4-Amino-5-phenyl-7-1-cyclobutyl-pyrrolo [2,3-d] pyrimidine derivatives | |
TR200001891T2 (en) | ASPB28- Human insulin and its use. | |
BRPI0512311A (en) | use of meloxicam in veterinary medicine for the treatment of painful inflammatory diseases | |
BRPI0410503B8 (en) | topical composition and use of composition | |
ATE226815T1 (en) | MANUFACTURING OF MEDICINAL PRODUCTS | |
PT1207756E (en) | USE OF ESPINOSADE OR A FORMULATION THAT INCLUDES ESPINOSADE | |
KR920007629A (en) | A pharmaceutical composition exhibiting activity in the treatment of neurological diseases of AIDS patients by containing at least one compound selected from SALMe salt, 5-MTHF and 5-FTHF as an active ingredient. | |
BRPI0411165A (en) | pharmaceutical composition, dosage unit form and methods for preparing its use | |
BR0318319A (en) | preparation methods and formulations / compositions sustained by the use of dimethicone as a vehicle | |
BR0110060A (en) | Transdermal or transmucosal pharmaceutical dosage form for the treatment of nicotine addiction or to accustom smokers and use of the dosage form | |
DE602006009259D1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING ORGANIC ORGANIC FUEL | |
DE69229318D1 (en) | Hydrogenated castor oil-containing injectable formulations with extended drug delivery | |
MXPA04011990A (en) | Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same. | |
BR0015770A (en) | Bicyclic analogues of vitamin D, use of a compound, pharmaceutical composition, cosmetic composition and use of a cosmetic composition | |
MXPA05013270A (en) | Transmucosal form of administration with reduced mucosal irritation. | |
ES2174533T3 (en) | USE OF A MIXTURE OF A DIOL AND AN ALFA-HYDROXY ACID FOR THE TREATMENT OF HYPERQUERATOTIC SKIN DISEASES. | |
BR0104761A (en) | Abamectin plus ivermectin combination for use as endectocide in cattle | |
BR0313503A (en) | Restless Leg Syndrome Treatment Method, Adenoin a2a Receptor Antagonist Use, Therapeutic Agent for Restless Leg Syndrome, and Night Myoclonus Treatment Method | |
Knight et al. | A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB) | |
BR0212744A (en) | Cisplatin formulations of reduced toxicity and methods for their use | |
BRPI0507144A (en) | powder formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11N | Dismissal: publication cancelled [chapter 11.14 patent gazette] |
Free format text: REFERENTE A RPI 1812 |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI |
|
B25C | Requirement related to requested transfer of rights |
Owner name: INSTITUTO DE PESQUISA EM SAUDE ANIMAL LTDA. (BR/MG Free format text: A FIM DE ATENDER A(S) TRANSFERENCIA(S), REQUERIDA(S) ATRAVES DA PETICAO NO 020130026576- RJ, DE 28/03/2013, E NECESSARIO APRESENTAR O CONTRATO SOCIAL DA EMPRESA CEDENTE PARA VERIFICAR SE O ASSINANTE DO DOCUMENTO DE CESSAO TEM PODERES PARA ALIENAR BENS. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: INTERVET INTERNATIONAL B.V. (NL) |